0001123292-17-001439.txt : 20170921
0001123292-17-001439.hdr.sgml : 20170921
20170921155405
ACCESSION NUMBER: 0001123292-17-001439
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170710
FILED AS OF DATE: 20170921
DATE AS OF CHANGE: 20170921
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Palczuk Linda
CENTRAL INDEX KEY: 0001717580
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32966
FILM NUMBER: 171095814
MAIL ADDRESS:
STREET 1: 7015 ALBERT EINSTEIN DRIVE
CITY: COLUMBIA
STATE: MD
ZIP: 21046
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: OSIRIS THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001360886
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 710881115
STATE OF INCORPORATION: MD
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7015 ALBERT EINSTEIN DRIVE
CITY: COLUMBIA
STATE: MD
ZIP: 21046
BUSINESS PHONE: 443-545-1819
MAIL ADDRESS:
STREET 1: 7015 ALBERT EINSTEIN DRIVE
CITY: COLUMBIA
STATE: MD
ZIP: 21046
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2017-07-10
0001360886
OSIRIS THERAPEUTICS, INC.
OSIR
0001717580
Palczuk Linda
7015 ALBERT EINSTEIN DRIVE
COLUMBIA
MD
21046
0
1
0
0
President & CEO
Incentive Stock Option (right to buy)
6.67
2017-07-10
4
A
0
25000
6.67
A
2018-07-10
2027-07-10
Common Stock
25000
25000
D
6,250 shares underlying this option shall vest on each of July 10, 2018, July 10, 2019, July 10, 2020, and July 10, 2021, subject to Reporting Person's continued service through the applicable vesting date.
/s/ Linda Palczuk
2017-09-21